Vivos Therapeutics, cardiovascular group partner to offer coordinated model for sleep therapy

LITTLETON, Colo. – Vivos Therapeutics, medical device and health care services company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from obstructive sleep apnea (OSA) and other health conditions, has executed definitive collaboration and operating agreements with South Palm Cardiovascular Associates (SPCVA) to support establishing and operating a regional Sleep & Airway Medicine Center (SAMC) in Palm Beach County, Fla. The agreements build on the collaboration announced on June 10, 2026, and provide the framework for the formation, capitalization, governance and operation of AIM Florida, a physician-aligned management services organization, including management services arrangements with affiliated clinical entities. Vivos expects to hold a 75% majority of the membership and economic interests in AIM Florida, subject to applicable regulatory requirements and the terms of the definitive agreements. "The execution of these definitive agreements is an important milestone in our strategy to partner directly with larger medical specialty groups and support their patients' sleep and airway needs,” said R. Kirk Huntsman, chairman and CEO of Vivos Therapeutics. “By combining SPCVA's trusted physician relationships with Vivos' technology and operating experience, we believe AIM Florida can expand access to comprehensive OSA care while creating a scalable and capital-efficient model for growth. Our SAMC model has been developed through our work in Colorado, Michigan and Nevada, and we believe the same operating framework can be successfully replicated in other markets. We continue to evaluate similar opportunities with medical groups in other U.S. markets." The operating plan calls for an initial fully staffed Sleep Optimization Team capable of serving approximately 250 patients per month. Based on its operating experience in Las Vegas and current assumptions, Vivos believes the initial team, once fully deployed, can generate up to $6 million in annual revenue with contribution margins of 30% or more.

• Related: Vivos to acquire sleep center.